Key result
Elective percutaneous coronary intervention for unprotected left main disease with paclitaxel-eluting stents resulted in a 15.8% rate of major adverse cardiac events at 2-year follow-up.
Why the study?
Does percutaneous coronary intervention with paclitaxel-eluting stents improve clinical outcomes in patients with unprotected left main disease?
Population
291 patients with unprotected left main disease undergoing elective percutaneous coronary intervention. Mean…
Design
Cohort
Follow-up
2 years
Authors
Loading...
Offers real-world benchmarks for PCI in unprotected left main; leaves open randomized comparison with bypass surgery.
Cohort (n=291)
Yes
Does percutaneous coronary intervention with paclitaxel-eluting stents improve clinical outcomes in patients with unprotected left main disease?
Elective percutaneous coronary intervention with paclitaxel-eluting stents for unprotected left main disease provides excellent acute angiographic results and favorable mid-term clinical outcomes, though side-branch stenting in bifurcation lesions increases the risk of stent thrombosis.
Vaquerizo et al. (2009) conducted a cohort in Unprotected left main disease (n=291). Percutaneous coronary intervention with paclitaxel-eluting stents was evaluated on Major adverse cardiac events (combined end point). Elective percutaneous coronary intervention for unprotected left main disease with paclitaxel-eluting stents resulted in a 15.8% rate of major adverse cardiac events at 2-year follow-up.
Synapse has enriched 3 closely related papers on similar clinical questions. Consider them for comparative context: